144 related articles for article (PubMed ID: 15051533)
1. Development and validation of a kinetic assay for analysis of anti-human interleukin-5 monoclonal antibody (SCH 55700) and human interleukin-5 interactions using surface plasmon resonance.
DiGiacomo RA; Xie L; Cullen C; Indelicato SR
Anal Biochem; 2004 Apr; 327(2):165-75. PubMed ID: 15051533
[TBL] [Abstract][Full Text] [Related]
2. Measuring binding kinetics of surface-bound molecules using the surface plasmon resonance technique.
Li B; Chen J; Long M
Anal Biochem; 2008 Jun; 377(2):195-201. PubMed ID: 18384740
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an immunoreceptor assay for simulect based on surface plasmon resonance.
Deckert F; Legay F
Anal Biochem; 1999 Oct; 274(1):81-9. PubMed ID: 10527499
[TBL] [Abstract][Full Text] [Related]
4. Qualification and application of a surface plasmon resonance-based assay for monitoring potential HAHA responses induced after passive administration of a humanized anti Lewis-Y antibody.
Szolar OH; Stranner S; Zinoecker I; Mudde GC; Himmler G; Waxenecker G; Nechansky A
J Pharm Biomed Anal; 2006 Jun; 41(4):1347-53. PubMed ID: 16644171
[TBL] [Abstract][Full Text] [Related]
5. Biosensor analysis of the interleukin-2 receptor complex.
Liparoto SF; Ciardelli TL
J Mol Recognit; 1999; 12(5):316-21. PubMed ID: 10556880
[TBL] [Abstract][Full Text] [Related]
6. Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance.
Ward LD; Shi PT; Simpson RJ
Biochem Int; 1992 Mar; 26(3):559-65. PubMed ID: 1627166
[TBL] [Abstract][Full Text] [Related]
7. Studies of interactions with weak affinities and low-molecular-weight compounds using surface plasmon resonance technology.
Strandh M; Persson B; Roos H; Ohlson S
J Mol Recognit; 1998; 11(1-6):188-90. PubMed ID: 10076837
[TBL] [Abstract][Full Text] [Related]
8. Optical biosensor-based characterization of anti-double-stranded DNA monoclonal antibodies as possible new standards for laboratory tests.
Buhl A; Page S; Heegaard NH; von Landenberg P; Luppa PB
Biosens Bioelectron; 2009 Sep; 25(1):198-203. PubMed ID: 19632822
[TBL] [Abstract][Full Text] [Related]
9. Surface plasmon resonance-enabled mass spectrometry arrays.
Nedelkov D; Tubbs KA; Nelson RW
Electrophoresis; 2006 Sep; 27(18):3671-5. PubMed ID: 16915566
[TBL] [Abstract][Full Text] [Related]
10. Surface plasmon resonance-enhanced fluorescence implementation of a single-step competition assay: demonstration of fatty acid measurement using an anti-fatty acid monoclonal antibody and a Cy5-labeled fatty acid.
Vareiro MM; Tranchant I; Maplin S; Zak K; Gani MM; Slevin CJ; Hailes HC; Tabor AB; Cameron PJ; Jenkins AT; Williams DE
Anal Biochem; 2008 Jun; 377(2):243-50. PubMed ID: 18381194
[TBL] [Abstract][Full Text] [Related]
11. Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies.
Lung FD; Chen CH; Liou CC; Chen HY
J Pept Res; 2004 Apr; 63(4):365-70. PubMed ID: 15102054
[TBL] [Abstract][Full Text] [Related]
12. At-line quantification of bioactive antibody in bioreactor by surface plasmon resonance using epitope detection.
Chavane N; Jacquemart R; Hoemann CD; Jolicoeur M; De Crescenzo G
Anal Biochem; 2008 Jul; 378(2):158-65. PubMed ID: 18457651
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antibody-antigen interactions: comparison between surface plasmon resonance measurements and high-mass matrix-assisted laser desorption/ionization mass spectrometry.
Bich C; Scott M; Panagiotidis A; Wenzel RJ; Nazabal A; Zenobi R
Anal Biochem; 2008 Apr; 375(1):35-45. PubMed ID: 18078803
[TBL] [Abstract][Full Text] [Related]
14. Optimizing recombinant antibody function in SPR immunosensing. The influence of antibody structural format and chip surface chemistry on assay sensitivity.
Townsend S; Finlay WJ; Hearty S; O'Kennedy R
Biosens Bioelectron; 2006 Aug; 22(2):268-74. PubMed ID: 16487701
[TBL] [Abstract][Full Text] [Related]
15. A quantitative human monoclonal antibody immunoassay using anti-idiotypic antibody as a membrane antigen surrogate with surface-plasmon-resonance detection.
Wong RB; Lee AH; Rangan VS; Cheng KC
Biotechnol Appl Biochem; 2009 May; 53(Pt 1):51-61. PubMed ID: 18680480
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.
Lu J; Witcher DR; White MA; Wang X; Huang L; Rathnachalam R; Beals JM; Kuhstoss S
Biochemistry; 2005 Aug; 44(33):11106-14. PubMed ID: 16101294
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions of phytochrome A (Pr vs. Pfr) with monoclonal antibodies probed by a surface plasmon resonance technique.
Natori C; Kim JI; Bhoo SH; Han YJ; Hanzawa H; Furuya M; Song PS
Photochem Photobiol Sci; 2007 Jan; 6(1):83-9. PubMed ID: 17200742
[TBL] [Abstract][Full Text] [Related]
18. Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique.
Pope ME; Soste MV; Eyford BA; Anderson NL; Pearson TW
J Immunol Methods; 2009 Feb; 341(1-2):86-96. PubMed ID: 19041872
[TBL] [Abstract][Full Text] [Related]
19. Determination of human growth hormone in human serum samples by surface plasmon resonance immunoassay.
Treviño J; Calle A; RodrÃguez-Frade JM; Mellado M; Lechuga LM
Talanta; 2009 May; 78(3):1011-6. PubMed ID: 19269465
[TBL] [Abstract][Full Text] [Related]
20. HAHA--nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology.
Nechansky A
J Pharm Biomed Anal; 2010 Jan; 51(1):252-4. PubMed ID: 19679421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
